Cancer Research AACR Conference on Molecular Diagnostics - 2008  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nam, S. W.
Right arrow Articles by Stracke, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nam, S. W.
Right arrow Articles by Stracke, M. L.
[Cancer Research 61, 6938-6944, September 15, 2001]
© 2001 American Association for Cancer Research


Tumor Biology

Autotaxin (NPP-2), a Metastasis-enhancing Motogen, Is an Angiogenic Factor

Suk Woo Nam1, Timothy Clair, Young-Sik Kim, Andrew McMarlin, Elliott Schiffmann, Lance A. Liotta and Mary L. Stracke

Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland 20892

Autotaxin [ATX (NPP-2)], originally isolated as a tumor motility-stimulating protein, has recently been shown to augment tumor aggressiveness. Specifically, atx-transfected, ras-transformed NIH3T3 cell lines have been shown to be more invasive, tumorigenic, and metastatic than mock-transfected ras-transformed control cells. In addition, the atx-transfected ras-transformed cell lines appeared to produce tumors that were much more hyperemic than those formed by appropriate control cells. This observation led to the present study, in which we demonstrate that ATX modulates angiogenesis both directly and indirectly. We have used a murine in vivo angiogenesis model in which treated Matrigel plugs are injected s.c. into athymic nude BALB/c mice. Using the same transfected cell lines as before, we found that mixing atx-transfected ras-transformed NIH3T3 cells into the Matrigel resulted in greater new blood vessel formation than control cells. Similarly, mixing purified ATX into the Matrigel resulted in new blood vessel formation within the plug, similar to that produced by vascular endothelial growth factor. Mechanistically, ATX is not a strong chemoattractant for human endothelial cells (HUVECs); however, it strongly stimulates motility in human coronary artery smooth muscle cells. In addition, ATX stimulates HUVECs grown on Matrigel to form tubules, much like vascular endothelial growth factor. Both of these normal cell types are shown to express and secrete ATX. In HUVECs, ATX expression is up-regulated by basic fibroblast growth factor in a time-dependent manner. This up-regulation also extends to secretion of enzymatically active protein, as demonstrated by Western blot analysis and quantification of type-1 phosphodiesterase activity. These results establish the presence of ATX in HUVECs and coronary artery smooth muscle cells and specify ATX as a novel angiogenic factor, suggesting that ATX could contribute to the metastatic cascade through multiple mechanisms, perhaps by supporting an invasive microenvironment for both normal and tumor cells.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
M. M. Ptaszynska, M. L. Pendrak, R. W. Bandle, M. L. Stracke, and D. D. Roberts
Positive Feedback between Vascular Endothelial Growth Factor-A and Autotaxin in Ovarian Cancer Cells
Mol. Cancer Res., March 1, 2008; 6(3): 352 - 363.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
A. D Singh, K. Sisley, Y. Xu, J. Li, P. Faber, S. J Plummer, H. S Mudhar, I. G Rennie, P. M Kessler, G. Casey, et al.
Reduced expression of autotaxin predicts survival in uveal melanoma
Br. J. Ophthalmol., October 1, 2007; 91(10): 1385 - 1392.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. E. Horak, J. H. Lee, A. G. Elkahloun, M. Boissan, S. Dumont, T. K. Maga, S. Arnaud-Dabernat, D. Palmieri, W. G. Stetler-Stevenson, M.-L. Lacombe, et al.
Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
Cancer Res., August 1, 2007; 67(15): 7238 - 7246.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Avraamides, M. E. Bromberg, J. P. Gaughan, S. M. Thomas, A. Y. Tsygankov, and T. S. Panetti
Hic-5 promotes endothelial cell migration to lysophosphatidic acid
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H193 - H203.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Tanaka, S. Okudaira, Y. Kishi, R. Ohkawa, S. Iseki, M. Ota, S. Noji, Y. Yatomi, J. Aoki, and H. Arai
Autotaxin Stabilizes Blood Vessels and Is Required for Embryonic Vasculature by Producing Lysophosphatidic Acid
J. Biol. Chem., September 1, 2006; 281(35): 25822 - 25830.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. L. Baker, Y. Fujiwara, K. R. Pigg, R. Tsukahara, S. Kobayashi, H. Murofushi, A. Uchiyama, K. Murakami-Murofushi, E. Koh, R. W. Bandle, et al.
Carba Analogs of Cyclic Phosphatidic Acid Are Selective Inhibitors of Autotaxin and Cancer Cell Invasion and Metastasis
J. Biol. Chem., August 11, 2006; 281(32): 22786 - 22793.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. A. van Meeteren, P. Ruurs, C. Stortelers, P. Bouwman, M. A. van Rooijen, J. P. Pradere, T. R. Pettit, M. J. O. Wakelam, J. S. Saulnier-Blache, C. L. Mummery, et al.
Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during Development.
Mol. Cell. Biol., July 1, 2006; 26(13): 5015 - 5022.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Kishi, S. Okudaira, M. Tanaka, K. Hama, D. Shida, J. Kitayama, T. Yamori, J. Aoki, T. Fujimaki, and H. Arai
Autotaxin Is Overexpressed in Glioblastoma Multiforme and Contributes to Cell Motility of Glioblastoma by Converting Lysophosphatidylcholine TO Lysophosphatidic Acid
J. Biol. Chem., June 23, 2006; 281(25): 17492 - 17500.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
S. Koike, K. Keino-Masu, T. Ohto, and M. Masu
The N-terminal hydrophobic sequence of autotaxin (ENPP2) functions as a signal peptide
Genes Cells, February 1, 2006; 11(2): 133 - 142.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. R. N. Baumforth, J. R. Flavell, G. M. Reynolds, G. Davies, T. R. Pettit, W. Wei, S. Morgan, T. Stankovic, Y. Kishi, H. Arai, et al.
Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells
Blood, September 15, 2005; 106(6): 2138 - 2146.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
G A Clines and T A Guise
Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone
Endocr. Relat. Cancer, September 1, 2005; 12(3): 549 - 583.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Jansen, C. Stefan, J. W. M. Creemers, E. Waelkens, A. Van Eynde, W. Stalmans, and M. Bollen
Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D
J. Cell Sci., July 15, 2005; 118(14): 3081 - 3089.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Sakagami, J. Aoki, Y. Natori, K. Nishikawa, Y. Kakehi, Y. Natori, and H. Arai
Biochemical and Molecular Characterization of a Novel Choline-specific Glycerophosphodiester Phosphodiesterase Belonging to the Nucleotide Pyrophosphatase/Phosphodiesterase Family
J. Biol. Chem., June 17, 2005; 280(24): 23084 - 23093.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. van Meeteren, P. Ruurs, E. Christodoulou, J. W. Goding, H. Takakusa, K. Kikuchi, A. Perrakis, T. Nagano, and W. H. Moolenaar
Inhibition of Autotaxin by Lysophosphatidic Acid and Sphingosine 1-Phosphate
J. Biol. Chem., June 3, 2005; 280(22): 21155 - 21161.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
D. H. Geho, R. W. Bandle, T. Clair, and L. A. Liotta
Physiological Mechanisms of Tumor-Cell Invasion and Migration
Physiology, June 1, 2005; 20(3): 194 - 200.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. S. ROGERS, R. M. ROHAN, A. E. BIRSNER, and R. J. D'AMATO
Genetic loci that control the angiogenic response to basic fibroblast growth factor
FASEB J, July 1, 2004; 18(10): 1050 - 1059.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Clair, J. Aoki, E. Koh, R. W. Bandle, S. W. Nam, M. M. Ptaszynska, G. B. Mills, E. Schiffmann, L. A. Liotta, and M. L. Stracke
Autotaxin Hydrolyzes Sphingosylphosphorylcholine to Produce the Regulator of Migration, Sphingosine-1-Phosphate
Cancer Res., September 1, 2003; 63(17): 5446 - 5453.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Ferry, E. Tellier, A. Try, S. Gres, I. Naime, M. F. Simon, M. Rodriguez, J. Boucher, I. Tack, S. Gesta, et al.
Autotaxin Is Released from Adipocytes, Catalyzes Lysophosphatidic Acid Synthesis, and Activates Preadipocyte Proliferation. UP-REGULATED EXPRESSION WITH ADIPOCYTE DIFFERENTIATION AND OBESITY
J. Biol. Chem., May 9, 2003; 278(20): 18162 - 18169.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Koh, T. Clair, E. C. Woodhouse, E. Schiffmann, L. Liotta, and M. Stracke
Site-directed Mutations in the Tumor-associated Cytokine, Autotaxin, Eliminate Nucleotide Phosphodiesterase, Lysophospholipase D, and Motogenic Activities
Cancer Res., May 1, 2003; 63(9): 2042 - 2045.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. B. Barden, K. W. Shister, B. Zhu, G. Guiter, D. Y. Greenblatt, M. A. Zeiger, and T. J. Fahey III
Classification of Follicular Thyroid Tumors by Molecular Signature: Results of Gene Profiling
Clin. Cancer Res., May 1, 2003; 9(5): 1792 - 1800.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Tokumura, E. Majima, Y. Kariya, K. Tominaga, K. Kogure, K. Yasuda, and K. Fukuzawa
Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase
J. Biol. Chem., October 11, 2002; 277(42): 39436 - 39442.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
W. H. Moolenaar
Lysophospholipids in the limelight: autotaxin takes center stage
J. Cell Biol., July 22, 2002; 158(2): 197 - 199.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.